(0.18%) 5 317.66 points
(0.21%) 39 991 points
(0.14%) 16 767 points
(0.61%) $79.11
(2.81%) $2.48
(-0.34%) $2 386.80
(0.68%) $29.93
(-0.32%) $1 066.70
(0.13%) $0.920
(0.29%) $10.70
(0.07%) $0.789
(0.16%) $90.83
4 days till quarter result
(bmo 2024-05-20)
Expected move: +/- 12.35%
Live Chart Being Loaded With Signals
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa...
Stats | |
---|---|
Today's Volume | 48 310.00 |
Average Volume | 400 304 |
Market Cap | 1.59M |
EPS | $0 ( 2024-05-13 ) |
Next earnings date | ( $0 ) 2024-05-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.630 |
ATR14 | $0.00700 (2.66%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-14 | Hull Andrew | Sell | 42 | Employee Stock Option (Expiration) |
2024-03-04 | Hsu Eric C | Sell | 309 | Employee Stock Option (Expiration) |
2024-01-21 | Mancini Alexandra Diane Janet | Sell | 121 | Employee Stock Option (Expiration) |
2024-02-20 | Jagpal Netta | Sell | 50 000 | Employee Stock Option (Right to Buy) |
2024-02-21 | Hull Andrew | Buy | 37 500 | Common Stock |
INSIDER POWER |
---|
75.06 |
Last 93 transactions |
Buy: 1 291 573 | Sell: 391 310 |
Volume Correlation
InMed Pharmaceuticals Correlation
10 Most Positive Correlations | |
---|---|
ZSAN | 0.901 |
KBSF | 0.889 |
BNOX | 0.885 |
ARQQ | 0.884 |
AYLA | 0.884 |
VIH | 0.884 |
LYRA | 0.882 |
BBCP | 0.882 |
QLGN | 0.881 |
HOFT | 0.879 |
10 Most Negative Correlations | |
---|---|
STAY | -0.89 |
AVGO | -0.884 |
TIPT | -0.883 |
BNIXU | -0.876 |
TVTY | -0.875 |
ARDX | -0.874 |
USLM | -0.872 |
LRFC | -0.869 |
LUNA | -0.864 |
PEBK | -0.862 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
InMed Pharmaceuticals Correlation - Currency/Commodity
InMed Pharmaceuticals Financials
Annual | 2023 |
Revenue: | $4.14M |
Gross Profit: | $1.40M (33.93 %) |
EPS: | $-3.25 |
FY | 2023 |
Revenue: | $4.14M |
Gross Profit: | $1.40M (33.93 %) |
EPS: | $-3.25 |
FY | 2022 |
Revenue: | $1.09M |
Gross Profit: | $543 546 (49.89 %) |
EPS: | $-41.74 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-38.00 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
InMed Pharmaceuticals
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of pain. In addition, it engages in the development of cannabinoid-based treatments for various diseases, including dermatology and ocular diseases. Further, the company works on IND-enabling pharmacology and preclinical toxicology studies; and IntegraSyn, an integrated biosynthesis-based manufacturing approach, for synthesizing pharmaceutical-grade cannabinoids. It has a research collaboration agreement with BayMedica Inc. for the manufacturing and testing of novel cannabinoid therapeutics. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators